Antifection

Albothricin is a potent streptothricin antibiotic that targets bacterial ribosomes, inhibiting protein synthesis. Its broad-spectrum antimicrobial activity is effective against various Gram-positive and Gram-negative bacteria, making it a valuable tool in microbial research. Albothricin is commonly utilized in studies focused on antibiotic resistance and the mechanism of action of antibacterial agents.

5′-Deoxythymidine is a thymidine analog with the 5' position substituted by hydrogen. This compound exhibits antimicrobial activity against Bacillus subtilis and Staphylococcus aureus. It serves as a valuable research tool in antiviral and anticancer studies, enabling investigations into nucleotide metabolism and cellular proliferation.

LY 186826 is a γ-lactam antibiotic that targets bacterial cell wall synthesis. This compound demonstrates potent antibacterial activity against a diverse array of both Gram-positive and Gram-negative bacteria, making it valuable for elucidating bacterial resistance mechanisms. Notably, LY 186826 is inactivated by β-lactamases and Enterobacterases, exhibiting enhanced efficacy against Enterobacter strains, which makes it an important tool in antibiotic resistance studies.

Bactobolin B (Alanylbactobolin) is a chlorine-containing antibiotic known for its antitumor properties. This compound exhibits biological activity against various bacterial strains and shows potential in cancer research. Its unique mechanism and effectiveness make it a valuable tool for investigating antibiotic resistance and cancer therapy.

Phenelfamycin F is an antibiotic that primarily targets and inhibits the growth of eutrophic bacteria. It exhibits significant antibacterial activity, making it valuable for research applications in microbiology and drug discovery. The compound can be used to study bacterial resistance mechanisms and evaluate potential therapeutic strategies against bacterial infections.

Musellactone is a lactone antibiotic derived from Musella lasiocarpa, exhibiting significant antibacterial activity against Bacillus megaterium and Sarcina lutea. This compound serves as a valuable tool for researchers investigating antimicrobial agents and exploring bacterial resistance mechanisms. Its efficacy makes it suitable for studying the pharmacological properties of natural products in the field of microbial research.

Pivmecillinam is an orally active prodrug of mecillinam, functioning primarily as a bacterial inhibitor. It exhibits potent activity against various gram-negative bacteria by interfering with the synthesis of bacterial cell walls. Pivmecillinam is utilized in research to investigate mechanisms of antibiotic resistance and the efficacy of beta-lactam antibiotics.

Aerocavin is an antibiotic that inhibits a broad spectrum of Gram-positive and Gram-negative bacteria, demonstrating bactericidal activity in vitro. This reagent is essential for research applications focusing on antibacterial mechanisms and the development of new antimicrobial agents. Its efficacy makes it a valuable tool for studying bacterial resistance and analyzing the pharmacodynamics of antibiotic compounds.

Quinocycline B is a quinone-containing glycoside antibiotic primarily targeting Gram-positive bacteria. Exhibiting potent antibacterial activity, it is effective against various strains that show resistance to common antibiotics. This compound is suitable for research applications in antibiotic resistance studies and the development of novel antimicrobial therapies.

Elsamicin B is an antitumor antibiotic that belongs to the Chartreusin group. It exhibits potent cytotoxic activity against a variety of cancer cell lines, making it a valuable tool for cancer research. Its mechanisms of action include DNA intercalation and disruption of topoisomerase activity, which contribute to its antitumor effects. Elsamicin B is utilized in studies focused on understanding cancer biology and the development of novel therapeutic strategies.

Plazomicin is a semi-synthetic aminoglycoside antibiotic that targets bacterial ribosomes by inhibiting protein synthesis. It serves as a substrate for aminoglycoside acetyltransferase and aminoglycoside phosphotransferase, yet remains resistant to common aminoglycoside-modifying enzymes. Plazomicin selectively inhibits MATE2-K and demonstrates significant activity against multidrug-resistant bacteria, including carbapenem-resistant Enterobacterales, making it valuable for research in antibiotic resistance and treatment efficacy studies.

Teicoplanin A2-2 is a glycopeptide antibiotic that targets bacterial cell wall synthesis. It demonstrates potent antibacterial activity, particularly against coagulase-negative staphylococci (CNS), by competitively binding to the terminal D-Ala-D-Ala peptide bonds, ultimately disrupting cell wall formation and leading to bacterial cell death. This compound is valuable for research into mechanisms of bacterial resistance and the development of novel antibiotic therapies.

Phleomycin E is an antitumor antibiotic that targets various Gram-positive bacteria, Gram-negative bacteria, and mycobacteria. It demonstrates significant antitumor activity by extending the survival time of mice bearing Ehrman’s ascites carcinoma, with an IC50 value of 0.31 μg/mL against airy entity carcinoma. This compound is valuable for research into cancer therapies and antibacterial applications.

10-Deoxymethymycin is an antibiotic that demonstrates significant antibacterial activity against Gram-positive bacteria. Its mechanism involves inhibition of bacterial protein synthesis, making it a valuable compound for research focused on combating antibiotic-resistant infections. This reagent is suitable for studies on antimicrobial efficacy and resistance mechanisms in bacteria.

Lankamycin is a macrolide antibiotic that exerts its effects through binding to the ribosome exit tunnel, thereby inhibiting protein synthesis in bacteria. It demonstrates moderate antimicrobial activity against various gram-positive bacterial strains. Lankamycin can be utilized in research to explore antibiotic resistance mechanisms and synergistic potential when combined with other antibiotics, such as Lankacidin C.

Parvodicin A is a glycopeptide antibiotic that primarily targets bacterial cell wall synthesis. It demonstrates significant inhibitory activity against Staphylococcus aureus, Staphylococcus furfur, Staphylococcus hemolyticus, and Enterococcus faecalis. This compound is valuable in antimicrobial research and development, particularly in the study of antibiotic resistance and the therapeutic action against multi-drug resistant strains.

2-Hydroxygentamicin A3 is an aminoglycoside antibiotic known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. This compound inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to disruptions in cellular processes. It is commonly utilized in research related to microbiology, infectious disease studies, and antibiotic resistance investigations.

1-Deamino-1-hydroxysagamicin is an aminoglycoside antibiotic that exhibits antimicrobial activity against both Gram-positive and Gram-negative bacteria. This compound is utilized in research applications for studying bacterial infections and antibiotic resistance mechanisms. Its broad-spectrum efficacy makes it a valuable tool for exploring the therapeutic potential of antibiotic compounds in microbial research.

Laidlomycin is a polyether antibiotic derived from Streptoverticillium olivoreticuli. It exhibits significant antibacterial activity against a range of Gram-positive bacteria, making it valuable for research in pharmacology and microbiology. Laidlomycin is commonly utilized in studies focused on antibiotic resistance mechanisms and the development of new antimicrobial therapies.

Pyridindolol K1 is an alkaloid antibiotic derived from Streptomyces species K93-0711. This compound exhibits potent antibacterial activity, making it a valuable tool for studying microbial resistance and antibiotic efficacy. Its applications include the exploration of mechanisms of action against Gram-positive and Gram-negative bacteria in various research settings.

N-(3-Oxobutanoyl)-L-homoserine lactone is an antibiotic autoregulator that plays a critical role in the biosynthesis of carbapenem antibiotics in Erwinia carotovora ATCC 39048. This compound is known to induce the expression of the rhiI gene in R. leguminosarum, highlighting its importance in bacterial communication and regulation. It is valuable for research on quorum sensing and antibiotic production pathways.

Polymyxin D1 is a heteropeptide antibiotic targeting the outer membrane of Gram-negative bacteria. It exhibits potent antibacterial activity, making it particularly effective against various strains of Gram-negative pathogens. This compound holds significant potential for research applications in the study of antibiotic resistance and the development of new therapeutic strategies against multidrug-resistant bacterial infections.

Monensin C is an oxygen-containing heterocyclic polyether antibiotic that primarily targets various microbial pathogens. It exhibits antibacterial, mycobacterial, antifungal, and protozoan activities. Notably, Monensin C has a reduced effectiveness against Gram-negative bacteria and demonstrates an inhibitory effect on HeLa cells. This compound is useful for research applications focusing on microbial resistance mechanisms and cellular responses to antibiotic treatments.

Mycinamicin VI is a macrolide antibiotic that primarily targets bacterial protein synthesis. It exhibits potent activity against Gram-positive bacteria, making it a valuable reagent for research into antimicrobial mechanisms and drug resistance. Mycinamicin VI is useful for studies focusing on bacterial infections and the development of novel antibacterial therapies.

Lankacyclinol A is an orally active antibiotic derived from Streptomyces rochei, demonstrating broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria. This compound shows low toxicity in murine models, making it a promising candidate for further research in infectious disease treatment and antibiotic development.

Raja 42 is a gamma lactam antibiotic that targets bacterial cell wall synthesis. It exhibits broad-spectrum efficacy against both Gram-positive and Gram-negative bacteria, including strains of Clostridium difficile. This compound is useful in microbiological research and antibiotic susceptibility studies.

Aerocyanidin is an antibiotic characterized by its isonitrile group, demonstrating potent activity against Gram-positive bacteria. Its mechanism of action involves inhibiting bacterial cell wall synthesis, making it a valuable tool in the study of bacterial resistance and the development of new antibacterial therapies. Research applications include investigating the efficacy of antibiotics and exploring bacterial susceptibility profiles.

Pluracidomycin C1 is a carbapenem antibiotic that exhibits potent antibacterial activity against both Gram-positive and Gram-negative bacteria. Its primary mechanism involves the inhibition of β-lactamase enzymes, enhancing its effectiveness against resistant strains. This compound is valuable for research applications focusing on antibiotic resistance and the development of new antimicrobial therapies.

Germicidin B is an antibiotic that exhibits bactericidal activity through the inhibition of hexokinase II, with an IC50 of 25.16 μM. It effectively suppresses spore germination in Streptomyces. Germicidin B is suitable for research applications focused on bacterial infections and antibiotic mechanisms.

Aplasmomycin is a boron-containing macrodiolide antibiotic targeting Gram-positive bacteria. It demonstrates potent antimicrobial activity and has been shown to inhibit plasmodium infections in vivo. This compound is useful in research applications focused on antibacterial and antimalarial effects, contributing to the understanding of microbial resistance and potential therapeutic strategies.

5-Hydroxymethyltubercidin, a semi-synthetic antibiotic derived from tuberculin-5-carboxylic acid, exhibits potent antibacterial activity. This compound is utilized in research to investigate mechanisms of antibiotic action and resistance, particularly in the context of bacterial infections. Its unique structure allows for the exploration of new therapeutic strategies against drug-resistant pathogens.

Exfoliamycin is a naphthoquinone antibiotic that exerts its antibacterial effects primarily against Gram-positive bacteria. Isolated from the actinobacterium Streptomyces Exfoliamycin Tu 1424, this compound has shown potential in various research applications, particularly in the study of bacterial resistance and antibiotic development. Its unique mechanism of action offers insights into antimicrobial strategies and therapeutic interventions.

Pneumocandin A1 is a lipopeptide antibiotic that specifically targets Candida species by inhibiting the synthesis of 1,3-β-D-glucan, a critical component of fungal cell walls. With an IC50 value of 0.07-0.5 μg/mL, it demonstrates potent antifungal activity in vitro. Pneumocandin A1 is primarily utilized in research applications focused on antifungal drug development and the study of fungal pathogenesis.

Bekanamycin sulfate is an aminoglycoside antibiotic with a primary mechanism of action targeting bacterial ribosomes, thereby inhibiting protein synthesis. As a minor component of the kanamycin complex, it exhibits significant antibacterial activity against a range of Gram-negative and some Gram-positive bacteria. This reagent is utilized in microbiological research and can be employed in studies assessing bacterial resistance and efficacy of antibiotic treatments.

Hongoquercin B is a sesquiterpene antibiotic with demonstrated activity against Vancomycin-resistant Enterococcus faecium, exhibiting its effects primarily at elevated concentrations. This compound is valuable for studying antibiotic resistance mechanisms and the development of novel antimicrobial strategies. Its specific interaction profiles make it a candidate for further exploration in antibiotic research and therapeutic applications.

A-25794 is an antibiotic that exhibits notable antidepressant properties. Primarily targeting bacterial infections, it has been identified for its potential effects on mood regulation. This compound may serve as a valuable tool in research focused on the intersection of antimicrobial treatments and mental health therapeutics.

Mycoplanecin A is a cyclic peptide antibiotic that primarily targets mycobacterial infections. It exhibits potent anti-mycobacterial activity, along with significant effects against Luteus and Hypococcus species. Additionally, Mycoplanecin A demonstrates moderate antibacterial efficacy against Xanthomonas oryzae and various strains of Actinomycetes, making it a valuable reagent for research in antibiotic resistance and microbial pathogenesis.

Leucomycin A4 is a macrolide antibiotic derived from Streptomyces kitasatoensis. It exhibits potent antibacterial activity against a range of pathogens, including Staphylococcus aureus, Bacillus subtilis, Corynebacterium diphtheriae, Neisseria gonorrhoeae, and Haemophilus influenzae, with minimum inhibitory concentrations (MICs) of 0.15, 1.25, 0.15, 0.6, and 0.15 µg/ml, respectively. Leucomycin A4 is utilized in microbial research and drug development as a crucial tool for studying antibiotic resistance and bacterial infections.

Tetromycin C1 is a potent fungicide derived from Streptomyces species, functioning primarily as an antibiotic bactericide. This compound exhibits significant biological activity against a variety of fungal pathogens, making it valuable for research applications focused on antifungal drug development and microbial resistance studies. Its unique mechanism of action provides insight into the biological processes that underlie fungal infections and their treatment.

Aibellin is a peptide antibiotic that exerts its primary action by modifying rumen fermentation processes. This compound is recognized for its ability to enhance microbial efficiency and nutrient absorption in ruminant livestock. Aibellin has significant implications in agricultural research, particularly in improving feed conversion and overall animal health.

Monamycin B is an ester peptide antibiotic targeting Gram-positive bacteria. This compound exhibits effective antibacterial properties, making it suitable for research applications related to microbial resistance and the development of new antimicrobial agents. Its unique mechanism of action contributes to its potential use in studying bacterial pathogenesis and antibiotic efficacy.

ME-1036 is a carbapenem antibiotic that exhibits potent activity against resistant Gram-positive organisms, including Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Additionally, it demonstrates efficacy against extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae. However, ME-1036 is not effective against Pseudomonas aeruginosa. This compound is valuable for research focused on antibiotic resistance and the development of novel therapeutic strategies.

Defucogilvocarcin V is a gilvocarcin antibiotic that primarily targets Gram-positive bacteria. It exhibits potent antibacterial activity, making it a valuable reagent for research focused on microbial infections. Its unique mechanism can be leveraged in studies exploring antibiotic resistance and the development of new therapeutic strategies.

Cinnabarin is an antibiotic extracted from the fungi Polystiotus cinnabarinus, P. versicolo, and Trametes cinnabarinus. It demonstrates antibacterial activity specifically against Gram-positive bacteria and possesses notable antiviral properties. This compound serves as a valuable tool in infectious disease research, offering insights into potential therapeutic applications and mechanisms of action.

2-Hydroxybutirosin is an antibiotic that inhibits bacterial protein synthesis, primarily targeting the ribosomal 50S subunit. Isolated from Bacillus circulans, it exhibits notable antibacterial activity against a spectrum of gram-positive bacteria. This compound is valuable for research in antibiotic resistance mechanisms and the development of novel antibacterial agents.

DQ 2556 is a semi-synthetic cephalosporin antibiotic that targets penicillin-binding proteins (PBPs). It exhibits notable bactericidal activity against both Gram-positive and Gram-negative bacteria, with particularly strong efficacy against Gram-positive strains and Enterobacteriaceae infections. By disrupting cell division, DQ 2556 demonstrates significant in vivo protective effects. This compound is valuable in the research and development of injectable cephalosporin formulations.

Gunacin is a quinone antibiotic that targets a broad spectrum of bacteria. It exhibits potent antibacterial activity against Gram-positive and Gram-negative bacteria, as well as mycoplasma. This compound is utilized in research applications aimed at understanding bacterial resistance mechanisms and exploring new therapeutic options.

Epoxyquinomicin B is an antibiotic sourced from Amycolatopsis sp., primarily targeting bacterial pathogens. It demonstrates significant inhibitory activity against Micrococcus luteus, Bacillus subtilis, Pasteurella piscicida, and Staphylococcus aureus, with a minimum inhibitory concentration (MIC) ranging from 6.25 to 12.5 µg/mL. Additionally, Epoxyquinomicin B exhibits cytotoxic effects in L1210 cancer cells, with an IC50 of 16.3 µg/mL, and shows potential anti-inflammatory properties in models of collagen-induced arthritis. Its diverse biological activities render it a valuable tool for research in microbiology and cancer therapeutics.

Monamycin F is an ester peptide antibiotic primarily targeting Gram-positive bacteria. It demonstrates significant antibacterial activity, making it a valuable tool for research in microbiology and antibiotic development. This compound is useful for studying bacterial resistance mechanisms and evaluating the efficacy of antibiotic therapies.

Oximidine III is an antitumor antibiotic that selectively inhibits the growth of 3Y1 rat fibroblast cells, demonstrating significant effects on various tumor-associated genes. It targets both v-H-ras-3Y1 and v-src-3Y1 cells, with IC50 values of 14 nM and 4.5 nM, respectively, while normal 3Y1 cells show an IC50 of 140 nM. Oximidine III effectively halts the cell cycle at the G1 phase in RAS or SRC-activated cells and promotes the expression of p21WAF1, making it valuable for research in cancer biology and therapeutic development.